| Scrip Code | 544666 |
|---|---|
| NSE Symbol | GKSL |
| MSEI Symbol | NOTLISTED |
| ISIN | INE0V0W01025 |
| Name of company | GUJARAT KIDNEY AND SUPER SPECIALITY LIMITED |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2026 |
| Date of end of financial year | 31-03-2027 |
| Date of board meeting when results were approved | 14-08-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 06-08-2026 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | First quarter |
| Nature of report standalone or consolidated | Standalone |
| Whether results are audited or unaudited for the quarter ended | Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | |
| Segment Reporting | Single segment |
| Description of single segment | HEALTHCARE INDUSTRY |
| Start date and time of board meeting | 14-08-2026 16:00:00 |
| End date and time of board meeting | 14-08-2026 17:00:00 |
| Whether cash flow statement is applicable on company | |
| Type of cash flow statement | |
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? | Yes |
| No. of times funds raised during the quarter | 1 |
| Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? | No |
| No default loan and Debt Securities | |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-04-2026 | 01-04-2026 |
| B | Date of end of reporting period | 30-06-2026 | 30-06-2026 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Standalone | Standalone |
| 1 | Income | ||
| Revenue from operations | 924.27 | 924.27 | |
| Other income | 64.52 | 64.52 | |
| Total income | 988.79 | 988.79 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 142.64 | 142.64 |
| (b) | Purchases of stock-in-trade | 0.00 | 0.00 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | 0.00 | 0.00 |
| (d) | Employee benefit expense | 149.71 | 149.71 |
| (e) | Finance costs | 35.17 | 35.17 |
| (f) | Depreciation, depletion and amortisation expense | 63.73 | 63.73 |
| (f) | Other Expenses | ||
| 1 | Other Expenses | 332.32 | 332.32 |
| Total other expenses | 332.32 | 332.32 | |
| Total expenses | 723.57 | 723.57 | |
| 3 | Total profit before exceptional items and tax | 265.22 | 265.22 |
| 4 | Exceptional items | 0.00 | 0.00 |
| 5 | Total profit before tax | 265.22 | 265.22 |
| 6 | Tax expense | ||
| 7 | Current tax | 63.30 | 63.30 |
| 8 | Deferred tax | (1.79) | (1.79) |
| 9 | Total tax expenses | 61.51 | 61.51 |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0.00 | 0.00 |
| 11 | Net Profit Loss for the period from continuing operations | 203.71 | 203.71 |
| 12 | Profit (loss) from discontinued operations before tax | 0.00 | 0.00 |
| 13 | Tax expense of discontinued operations | 0.00 | 0.00 |
| 14 | Net profit (loss) from discontinued operation after tax | 0.00 | 0.00 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0.00 | 0.00 |
| 16 | Total profit (loss) for period | 203.71 | 203.71 |
| 17 | Other comprehensive income net of taxes | (0.29) | (0.29) |
| 18 | Total Comprehensive Income for the period | 203.42 | 203.42 |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | |||
| Total profit or loss, attributable to non-controlling interests | |||
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | |||
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | |||
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 1,576.87 | 1,576.87 | |
| Face value of equity share capital | 2 | 2 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | ||
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 0.26 | 0.26 | |
| Diluted earnings (loss) per share from continuing operations | 0.26 | 0.26 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 0.26 | 0.26 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 0.26 | 0.26 | |
| 24 | Debt equity ratio | ||
| 25 | Debt service coverage ratio | ||
| 26 | Interest service coverage ratio | ||
| 27 | Disclosure of notes on financial results | ||
| Debt equity ratio | |
|---|---|
| Debt service coverage ratio | |
| Interest service coverage ratio |
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-04-2026 | 01-04-2026 | |||||
| Date of end of reporting period | 30-06-2026 | 30-06-2026 | |||||
| Whether results are audited or unaudited | Unaudited | Unaudited | |||||
| Nature of report standalone or consolidated | Standalone | Standalone | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| Total Segment Revenue | |||||||
| Less: Inter segment revenue | |||||||
| Revenue from operations | |||||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| Total Profit before tax | |||||||
| i. Finance cost | |||||||
| ii. Other Unallocable Expenditure net off Unallocable income | |||||||
| Profit before tax | |||||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| Total Segment Asset | |||||||
| Un-allocable Assets | null | null | |||||
| Net Segment Asset | null | null | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| Total Segment Liabilities | |||||||
| Un-allocable Liabilities | null | null | |||||
| Net Segment Liabilities | null | null | |||||
| Disclosure of notes on segments | |||||||
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-04-2026 | 01-04-2026 |
| B | Date of end of reporting period | 30-06-2026 | 30-06-2026 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Standalone | Standalone |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Item that will not be reclassified to profit or loss | (0.39) | (0.39) |
| Total Amount of items that will not be reclassified to profit and loss | (0.39) | ||
| 2 | Income tax relating to items that will not be reclassified to profit or loss | (0.10) | (0.10) |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| Total Amount of items that will be reclassified to profit and loss | |||
| 4 | Income tax relating to items that will be reclassified to profit or loss | 0.00 | 0.00 |
| 5 | Total Other comprehensive income | (0.29) | (0.29) |
| Whether results are audited or unaudited | Unaudited |
|---|---|
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Auditor's opinion | |
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results | Yes |
| Sr No. | Audit firm's name | Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI | Certificate valid upto | ||
| 1 | Y M Shah & Co | Yes | 30-06-2027 | ||
|---|---|---|---|---|---|
| Mode of Fund Raising | Public Issues |
|---|---|
| Description of mode of fund raising (Applicable in case of others is selected) | |
| Date of Raising Funds | 24-12-2025 |
| Amount Raised | 25,080.00 |
| Report filed for Quarter ended | 30-06-2026 |
| Monitoring Agency | Applicable |
| Monitoring Agency Name, if applicable | Brickwork ratings India Private Limited |
| Is there a Deviation / Variation in use of funds raised | Yes |
| If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders | Yes |
| If Yes, Date of shareholder Approval | 25-04-2026 |
| Explanation for the Deviation / Variation | |
| Comments of the Audit Committee after review | No Comments |
| Comments of the auditors, if any | No Comments |
| Sr. | Original Object | Modified Object, if any | Original Allocation | Modified allocation, if any | Funds Utilised | Amount of Deviation/Variation for the quarter according to applicable object | Remarks if any |
| 1 | Proposed acquisition of “Parekhs Hospital Private Limited” at Ahmedabad | NO | 7,700.00 | 0.00 | 7,700.00 | 0.00 | |
| 2 | Part payment of purchase consideration for the already acquired hospital i.e. “Ashwini Medical Centre | NO | 1,240.00 | 0.00 | 1,240.00 | 0.00 | |
| 3 | Acquisition of additional shareholding in our subsidiary namely “Harmony Medicare Private Limited” at Bharuch | NO | 1,078.00 | 0.00 | 1,078.00 | 0.00 | |
| 4 | Funding of capital expenditure requirements of our Company towards setting up of a new hospital exclusively for women’s health care in Vadodara; | Healthcare expansion aligned with the company’s main IPO object, including development and operation of Mult speciality hospital project in Bharuch through a newly incorporated private company | 3,010.00 | 2,515.00 | 495.00 | 0.00 | Object varied through special resolution approved by Shareholders vide Postal ballot on 25.04.2026. But no amount was utilised. |
| 5 | Buying robotics equipment for our hospital Gujarat Kidney & Super Speciality hospital at Vadodara location | Setting up and Operating Dialysis services through deployment of Dialysis machine and Digital patient Monitoring solution by way of collaborating with Lord’s Mark Industries Limited | 683.00 | 683.00 | 683.00 | 0.00 | Object varied through special resolution approved by Shareholders vide Postal ballot on 25.04.2026. Aamount was utilised fully. |
| 6 | Full or part repayment and/or prepayment of certain outstanding secured borrowings availed by our Company | NO | 120.00 | 0.00 | 120.00 | 0.00 | |
| 7 | Funding inorganic growth through unidentified acquisitions and General Corporate Purposes. | NO | 8,744.00 | 0.00 | 7,482.00 | 0.00 | |
| 8 | issue expenses | NO | 2,505.00 | 0.00 | 2,463.00 | 0.00 |
| Name of signatory | Vishakha Phadke |
| Designation of person | Company Secretary and Compliance Officer |
| Place | Vadodara |
| Date | 14-08-2026 |